kuvura kanseri y'ibihaha imiti ivura ikiguzi

Kumva ikiguzi cya Kanseri y'ibihaha Imiti yo kuvuraIyi ngingo itanga incamake yuzuye yikiguzi kijyanye nibintu bitandukanye kuvura kanseri y'ibihaha imiti, igufasha kuyobora iyi miterere igoye. Tuzashakisha uburyo butandukanye bwo kuvura, ibintu bigira ingaruka kubiciro, nibikoresho bihari kugirango dukoreshe amafaranga. Aya makuru ni ayubumenyi rusange kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza abashinzwe ubuzima kugirango bakuyobore kugiti cyawe.

Ubwoko bwa Kanseri y'ibihaha Imiti yo kuvura

Ubuvuzi bugamije

Ubuvuzi bugamije gukora bwibanda kuri molekile zihariye zigira uruhare mu mikurire ya kanseri. Ingero zirimo EGFR inhibitor (nka Gefitinib na Erlotinib), inhibitor za ALK (nka Crizotinib na Alectinib), nibindi. Igiciro cyiyi miti kiratandukanye bitewe nibiyobyabwenge byihariye, urugero, nigihe cyo kwivuza. Iyi miti irashobora kubahenze cyane, akenshi igura ibihumbi byamadorari buri kwezi.

Chimoterapi

Imiti ya chimiotherapie yica kanseri igabanya vuba. Imiti ikoreshwa cyane muri kanseri yibihaha harimo cisplatine, karboplatine, paclitaxel, na docetaxel. Nubwo muri rusange bihenze ugereranije nubuvuzi bugenewe kuri dose, igiteranyo cyo gukusanya imiti ya chimiotherapie kirashobora kuba kinini kubera inshuro nigihe cyo kwivuza.

Immunotherapy

Immunotherapy ifasha umubiri wawe kwirinda indwara ya kanseri. Ibiyobyabwenge nka pembrolizumab (Keytruda) na nivolumab (Opdivo) ni ingero z'imiti ikingira indwara ikoreshwa mu kuvura kanseri y'ibihaha. Kimwe nubuvuzi bugamije, imiti ikingira indwara irashobora kubahenze cyane.

Indi miti

Imiti yinyongera irashobora gukoreshwa mugukemura ingaruka zijyanye no kuvura kanseri, bikongeraho kumafaranga yose. Ibi birashobora kubamo imiti irwanya isesemi, kugabanya ububabare, n'imiti yo gukemura izindi ngorane.

Ibintu bigira ingaruka kubiciro bya Imiti ivura kanseri y'ibihaha

Ibintu byinshi bigira uruhare mubiciro rusange bya kuvura kanseri y'ibihaha:

Ikintu	Ingaruka ku Biciro
Ubwoko bw'imiti	Ubuvuzi bugenewe hamwe na immunotherapie muri rusange bihenze kuruta chimiotherapie.
Umubare nigihe cyo kwivuza	Umubare munini hamwe nigihe kinini cyo kuvura byongera ibiciro muri rusange.
Ubwishingizi	Ingano yubwishingizi bwawe igira ingaruka zikomeye kumafaranga yakoreshejwe.
Aho bivuriza	Ibiciro birashobora gutandukana ukurikije aho utuye hamwe nubuvuzi bwihariye.

Gucunga ibiciro bya Kuvura Kanseri y'ibihaha

Guhangana nigiciro kinini cya imiti ivura kanseri y'ibihaha birashobora kuba byinshi. Nyamara, hari ibikoresho biboneka byafasha: Ubwishingizi bwubwishingizi: Sobanukirwa na politiki yubwishingizi hamwe nubwishingizi bwokuvura kanseri. Menyesha uwaguhaye ubwishingizi kugirango asobanure ibibazo byose. Gahunda yo Gufasha Amafaranga: Ibigo bikorerwamo ibya farumasi akenshi bitanga gahunda zifasha abarwayi kugirango bifashe kugabanya ibiciro byimiti yabo. Reba hamwe nuwakoze imiti yagenwe. Amashyirahamwe y'abagiraneza: Amashyirahamwe menshi atanga ubufasha bwamafaranga kubarwayi ba kanseri bafite ibibazo byubukungu. Amashyirahamwe yubushakashatsi mukarere kawe cyangwa mugihugu. Kuganira nabatanga serivisi: Muganire kuburyo bwo kwishyura hamwe na gahunda zishobora gufasha amafaranga hamwe n’ushinzwe ubuzima cyangwa ishami ryabo ryishyuza. Uwiteka Shandong Baofa Ikigo Cyubushakashatsi Kanseri itanga ubuvuzi bwuzuye hamwe na gahunda zitandukanye zo kwishyura.

Ibindi bikoresho

Kubindi bisobanuro birambuye kuri kuvura kanseri y'ibihaha n'ibiciro bifitanye isano, baza inama ya oncologue cyangwa urebe amasoko azwi nk'ikigo cy'igihugu gishinzwe kanseri (NCI) na Sosiyete y'Abanyamerika ishinzwe kanseri (ACS). Wibuke, kubona gahunda nziza yo gusuzuma no kuvura ningirakamaro mugucunga ubuzima bwawe no kugendana nubukungu bwokwitaho. Gushyikirana kumugaragaro nitsinda ryanyu ryubuzima ni ngombwa. Kugisha inama numujyanama wimari kabuhariwe mubiciro byubuzima nabyo birashobora kuba ingirakamaro.